Transgene Biotek share news, announcements and annual reports
BSE: 526139Healthcare ServicesSmall Cap
Transgene Biotek Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1993
Last close ₹2.33down ₹0.09 (3.72%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹2.42.
30 Oct: open ₹2.59, high ₹2.59, low ₹2.26
52-week range of traded prices to 30 Oct 2026
₹1.83Low, 4 Feb 2026₹4.19High, 30 Oct 2025
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18 Cr4,238th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.11
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.05
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 43,282
Transgene Biotek shareholder meetings
52 filed, newest first. Page 1 of 2.
Sep 2026
Dec 2025
30 Dec · Meeting
30 Dec · Meeting
30 Dec · Meeting
5 Dec · Meeting
Sep 2025
Dec 2024
5 Dec · Meeting
Nov 2024
Aug 2024
Jan 2024
Dec 2023
1 Dec · Meeting
Aug 2023
Oct 2022
1 Oct · Meeting
1 Oct · Meeting
Sep 2022
Oct 2021
Sep 2021
Aug 2021
Oct 2020
Sep 2020
30 Sep · Meeting
Aug 2020
Sep 2019
Aug 2019
Dec 2018
Nov 2018
Sep 2018
Sep 2017
30 Sep · Meeting
Aug 2017
Oct 2016
Sep 2016
2 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 28, 2016 to September 30, 2016 (both days inclusive) ....
Oct 2015
Jan 2015
Dec 2014
8 Dec · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from December 29, 2014 to December 31, 2014 (both days inclusive) ....
Sep 2013
Aug 2013
19 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2013 to September 26, 2013 (both days inclusive) ....
Nov 2012
7 Nov · Meeting
Resolution proposed through the notice of postal ballot dated September 20, 2012 for delisting of Equity Shares of the Company from the Indian ....
Oct 2012
17 Oct · Meeting
With reference to the earlier announcement regarding Notice of Postal Ballot wherein the Company had mentioned the date of postal ballot results on November 06, 2012 at 5.30 p.m., Transgene ....
Sep 2012
10 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 26, 2012 to September 29, 2012 (both days inclusive) ....
Oct 2011
3 Oct · Meeting
Members at the 21st Annual General Meeting (AGM) of the Company held on September 30, 2011, inter alia, have passed the following resolutions: ....
Sep 2011
7 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 28, 2011 to September 30, 2011 (both days inclusive) ....
Apr 2011
25 Apr · Meeting
Members at the Extra Ordinary General Meeting (EGM) of the Company held on April 18, 2011, have given their fresh consent for the allotment ....
Mar 2011
30 Mar · Meeting
An Extra Ordinary General Meeting (EGM) of the members of the Company will be held on April 18, 2011, for obtaining the fresh consent for the ....